A Synthetic Cell-Penetrating Peptide Antagonizing TrkA Function Suppresses Neuropathic Pain in Mice

Nerve growth factor (NGF) and its high-affinity receptor, TrkA, are one of the targets in the production of new drugs for the treatment of neuropathic pain. NGF contributes to both the initiation and maintenance of sensory abnormalities after peripheral nerve injury. This study examined the effects...

Full description

Saved in:
Bibliographic Details
Main Authors: Wei-Ying Ma (Author), Eri Murata (Author), Koyo Ueda (Author), Yoshihiro Kuroda (Author), Ming-Hui Cao (Author), Mineo Abe (Author), Kenji Shigemi (Author), Munetaka Hirose (Author)
Format: Book
Published: Elsevier, 2010-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_b6f9c57fa63e48a383dcca5573bfd4d0
042 |a dc 
100 1 0 |a Wei-Ying Ma  |e author 
700 1 0 |a Eri Murata  |e author 
700 1 0 |a Koyo Ueda  |e author 
700 1 0 |a Yoshihiro Kuroda  |e author 
700 1 0 |a Ming-Hui Cao  |e author 
700 1 0 |a Mineo Abe  |e author 
700 1 0 |a Kenji Shigemi  |e author 
700 1 0 |a Munetaka Hirose  |e author 
245 0 0 |a A Synthetic Cell-Penetrating Peptide Antagonizing TrkA Function Suppresses Neuropathic Pain in Mice 
260 |b Elsevier,   |c 2010-01-01T00:00:00Z. 
500 |a 1347-8613 
500 |a 10.1254/jphs.10119FP 
520 |a Nerve growth factor (NGF) and its high-affinity receptor, TrkA, are one of the targets in the production of new drugs for the treatment of neuropathic pain. NGF contributes to both the initiation and maintenance of sensory abnormalities after peripheral nerve injury. This study examined the effects of IPTRK3, a new synthetic cell-penetrating peptide that antagonizes TrkA function, on neuropathic pain in mice. Partial sciatic nerve ligation (PSNL) was used to generate neuropathic pain, and we injected IPTRK3 (2 or 10 mg/kg) intraperitoneally on day 7 after PSNL. Effects of the peptide on hyperalgesia, allodynia, and expression of Fos in the spinal cord were examined. Single administration of the peptide on day 7 significantly suppressed both thermal hyperalgesia and mechanical allodynia. Gentle touch stimuli-evoked Fos expression in the lumbar spinal cord was also significantly reduced. Intraperitoneal injection of a cell-penetrating peptide antagonizing TrkA function appears effective for treatment of neuropathic pain in a mouse pain model. Keywords:: cell-penetrating peptide, neuropathic pain, Tat, TrkA 
546 |a EN 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Journal of Pharmacological Sciences, Vol 114, Iss 1, Pp 79-84 (2010) 
787 0 |n http://www.sciencedirect.com/science/article/pii/S1347861319308825 
787 0 |n https://doaj.org/toc/1347-8613 
856 4 1 |u https://doaj.org/article/b6f9c57fa63e48a383dcca5573bfd4d0  |z Connect to this object online.